Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Change in Receivables: 2024

Historic Change in Receivables for Syndax Pharmaceuticals (SNDX) over the last 1 years, with Dec 2024 value amounting to $7.6 million.

  • Syndax Pharmaceuticals' Change in Receivables rose 197.93% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.9 million, marking a year-over-year change of. This contributed to the annual value of $7.6 million for FY2024, which is N/A change from last year.
  • Syndax Pharmaceuticals' Change in Receivables amounted to $7.6 million in FY2024.
  • Syndax Pharmaceuticals' Change in Receivables' 5-year high stood at $7.6 million during FY2024, with a 5-year trough of $7.6 million in FY2024.
  • Moreover, its 1-year median value for Change in Receivables was $7.6 million (2024), whereas its average is $7.6 million.